Restrictive Lung Diseases
- Immunosuppression Linked to Improved Pulmonary Function in RA-ILD
- Severity of GERD Symptoms in Systemic Sclerosis Associated With ILD Progression
- Distinct Lung Function Trajectories Identified in Idiopathic Pulmonary Fibrosis
- Reliable Biomarkers Identified for Diagnosing Systemic Sclerosis-ILD
- Methotrexate Protective Against Mortality and Lung Function Decline in RA-ILD
- Pirfenidone Promising for RA-Linked Interstitial Lung Disease
- Patients With RA-ILD Have Increased Risk for Severe COVID-19
- High-Dose Treprostinil Helps Pulmonary Hypertension in Interstitial Lung Disease
- Pirfenidone Benefits Patients With Arthritis-Associated Interstitial Lung Disease
- Orkambi Indication Expanded to Include More Children With Cystic Fibrosis
- Risk Stratification in Cystic Fibrosis Patients Listed for Lung Transplantation
- Erythema Nodosum Linked to Better Prognosis in Patients With Sarcoidosis
Conference Coverage
MORE MEETINGS
Clinical Tools
Powered by
Powered by 
